Panion & Bf Biotech Inc. (TPE:1760)

Market Cap	5.34B -23.8%
Revenue (ttm)	2.04B +0.2%
Net Income	174.37M +43.7%
EPS	2.03 +43.5%
Shares Out	85.74M
PE Ratio	30.69
Forward PE	n/a
Dividend	1.80 (2.91%)
Ex-Dividend Date	Jun 12, 2025

Volume	117,136
Average Volume	206,171
Open	62.40
Previous Close	62.30
Day's Range	61.20 - 62.40
52-Week Range	56.00 - 89.90
Beta	-0.03
RSI	40.05
Earnings Date	Mar 9, 2026

About Panion & Bf Biotech

Panion & Bf Biotech Inc., a biotechnology pharmaceutical company, provides western medicines, cosmetics, testing reagents, food and chemical products in Taiwan, the United States, China, Hong Kong, Macau, and internationally. The company offers products in the areas of antibody, respiratory, gastrointestinal, COVID-19 IVD, antigen, anti-aging, active pharmaceutical ingredients, disease treatment, prevention, and veterinary products. It also offers nephrology, dermatology, pain management, hospital and household sanitization, and personal hygien...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1976
• Country: Taiwan
• Stock Exchange: Taiwan Stock Exchange
• Ticker Symbol: 1760

Financial Performance

In 2024, Panion & Bf Biotech's revenue was 2.03 billion, an increase of 7.85% compared to the previous year's 1.88 billion. Earnings were 124.52 million, an increase of 61.26%.